Bio Vaccines (India) Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.90 Cr
as on 16-11-2024
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.55 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.15 Cr
as on 16-11-2024
- Revenue -14.22%
(FY 2023)
- Profit 26.01%
(FY 2023)
- Ebitda 57.63%
(FY 2023)
- Net Worth -30.03%
(FY 2023)
- Total Assets -14.85%
(FY 2023)
About Bio Vaccines (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.90 Cr.
The company currently has active open charges totaling ₹7.55 Cr. The company has closed loans amounting to ₹4.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Urmil Arora and Manorma serve as directors at the Company.
- CIN/LLPIN
U24230DL2010PTC265256
- Company No.
265256
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bio Vaccines (India)?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Urmil Arora | Director | 03-Sep-2011 | Current |
Manorma | Director | 07-Jun-2024 | Current |
Financial Performance of Bio Vaccines (India).
Bio Vaccines (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.22% decrease. The company also saw a substantial improvement in profitability, with a 26.01% increase in profit. The company's net worth observed a substantial decline by a decrease of 30.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bio Vaccines (India)?
In 2023, Bio Vaccines (India) had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.55 Cr
₹4.15 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 7.55 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
14 Aug 2013 | State Bank Of India | ₹7.55 Cr | Open |
01 Dec 2010 | Punjab National Bank | ₹4.15 Cr | Satisfied |
How Many Employees Work at Bio Vaccines (India)?
Unlock and access historical data on people associated with Bio Vaccines (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio Vaccines (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Vaccines (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.